Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis

• Główni autorzy: Qi-An Chen (Autor), Wei-Hao Lin (Autor), Xiao-Xiang Zhou (Autor), Zheng Cao (Autor), Xiao-Li Feng (Autor), Yi-Bo Gao (Autor), Jie He (Autor)
• Format: Książka
• Wydane: Elsevier, 2024-02-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Objective: To assess the efficacy and safety of FDA-approved KRASG12C inhibitors in patients with KRASG12C-mutated solid tumors. Methods: We searched PubMed, EMBASE, Cochrane Library, and major international conferences for clinical trials published in English up to March 6, 2023. Clinical trials in...